Divine Skin To Begin Manufacturing Its OTC Pain Reliever
MIAMI BEACH, Fla., June 26, 2012 -- Divine Skin Inc. (DSKX) (OTC Bulletin Board: DSKX) Divine Skin today announced that it was granted a Drug Enforcement Agency license in partnership with its manufacturing partner to produce and distribute Ephedrine containing drugs and other controlled substances.
The Company has started working on a new OTC analgesic, which it believes could provide an alternative to current OTC pain relievers. Receiving this mandatory license is the final step in commencing manufacturing of its OTC pain reliever.
In the United States alone, manufacturers' revenue from internal non-narcotic analgesics, antipyretics, anti-arthritics, and anti-inflammatories, including salicylates and acetaminophen, totaled $2.4 billion in 2009, according to an August 2010 report published by the US Census Bureau.
About Divine Skin
Divine Skin Inc. is a leader in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices.
DS Laboratories, its flagship brand, offers high-performance topical solutions for a wide range of personal care needs. Bioavailability is enhanced through Nanosome encapsulation (www.DSLaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging (SigmaSkin.com).
Polaris Research Laboratories makes high-potency hair-growth formulas (Polarisresearchlabs.com).
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers. (ThePureGuild.com).
